文献速递血液透析通路

门诊头臂型动静脉瘘建立中麻醉类型与结局的关联

Association of Anesthesia Type with Outcomes after Outpatient Brachiocephalic Arteriovenous Fistula Creation.
PubMed 文献 · Ann Vasc Surg · 2020-06-03

本研究基于血管质量倡议(VQI)2011-2018年全国数据库,分析3,527例门诊头臂型动静脉瘘(BCF)建立病例,比较全身麻醉(GA)与区域/局部麻醉(RA/LA)的围手术期及1年结局。结果显示GA与术后住院率增加、3个月通路使用率降低相关,但1年通路闭塞和无再干预生存率相似;RA/LA可能更有利于加速康复和通路使用。

要点

  • 门诊BCF建立中,GA与RA/LA相比术后住院风险更高(OR 1.7)。
  • GA组3个月透析通路使用率显著低于RA/LA组(OR 0.39)。
  • GA与RA/LA的1年通路闭塞和无再干预生存率无显著差异。

核心结论

  • 门诊BCF建立中,GA与术后住院增加和3个月通路使用减少相关,但1年通路闭塞和再干预率与RA/LA相似。
  • RA/LA可能优于GA以加速康复和通路使用。

研究设计与样本

  • 回顾性队列研究,查询Vascular Quality Initiative(2011-2018)全国数据库中门诊BCF建立病例。
  • 共纳入3,527例门诊BCF建立,麻醉方式为GA 1,043例(29.6%)、RA 1,150例(32.6%)、LA 1,334例(37.8%)。
  • 比较GA与RA/LA的围手术期、3个月和1年结局。

主要发现

  • GA组3个月通路使用率低于RA/LA组(12.6% vs. 23.6%,P < 0.001)。
  • Kaplan-Meier分析显示GA与RA/LA的1年 primary access occlusion-free survival 相似(43.6% vs. 47.1%,P = 0.24),endovascular/open reintervention-free survival 相似(57.2% vs. 57.6%,P = 0.98)。
  • 多变量分析中,GA与RA/LA相比独立关联术后住院增加(OR 1.7,95%CI 1.08-2.67,P = 0.02)和3个月通路使用减少(OR 0.39,95%CI 0.25-0.61,P < 0.001),但1年通路闭塞(HR 1.09,95%CI 0.9-1.32,P = 0.36)和再干预(HR 1.02,95%CI 0.82-1.26,P = 0.88)相似。
  • RA/LA亚组分析中,RA与LA相比与3个月通路使用增加(OR 1.6,95%CI 1.01-2.5,P = 0.04)和1年通路再干预增加(HR 1.46,95%CI 1.12-1.89)相关,但1年通路闭塞相似(HR 1.2,95%CI 0.95-1.51,P = 0.13)。

临床怎么用

  • 门诊BCF建立时,优先考虑RA/LA而非GA,以减少术后住院并促进3个月通路使用。
  • 选择RA时需权衡3个月通路使用增加与1年再干预风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Brachiocephalic arteriovenous fistulas (BCFs) are commonly placed in outpatient settings. The impact of general anesthesia (GA), regional anesthesia (RA), or local anesthesia (LA) on perioperative recovery and fistula maturation/patency after outpatient BCF creations is unknown. We evaluated whether outcomes of outpatient BCF creations vary based on anesthesia modality. METHODS: The Vascular Quality Initiative (2011-2018) national database was queried for outpatient BCF creations. Anesthesia modalities included GA, RA, and LA. Perioperative, 3-month, and 1-year outcomes were compared between GA versus RA/LA anesthesia types. RESULTS: Among 3,527 outpatient BCF creations, anesthesia types were GA in 1,043 (29.6%), RA in 1,150 (32.6%), and LA in 1,334 (37.8%). Patients receiving GA were more often younger, obese, Medicaid recipients, without coronary artery disease, and treated in non-office-based settings (P < 0.05 for all). GA compared with RA/LA cohorts were more often admitted postoperatively (5.3% vs. 2.4%, P < 0.001) but had similar rates of thirty-day mortality (0.9 vs. 0.6%, P = 0.39). 3-month access utilization for hemodialysis was lower in GA than in RA/LA cohorts (12.6% vs. 23.6%, P < 0.001). The Kaplan-Meier analysis showed that GA and RA/LA cohorts had similar 1-year primary access occlusion-free survival (43.6% vs. 47.1%, P = 0.24) and endovascular/open reintervention-free survival (57.2% vs. 57.6%, P = 0.98). On multivariable analysis, GA compared with RA/LA use was independently associated with increased postoperative admission (odds ratio [OR]: 1.7, 95% confidence interval [CI]: 1.08-2.67, P = 0.02) and decreased 3-month access utilization (OR: 0.39, 95% CI: 0.25-0.61, P < 0.001) but had similar 1-year access occlusion (hazard ratio [HR]: 1.09, 95% CI: 0.9-1.32, P = 0.36) and reintervention (HR: 1.02, 95% CI: 0.82-1.26, P = 0.88). On subgroup analysis of the RA/LA cohort, RA compared with LA was associated with increased 3-month access utilization (OR: 1.6, 95% CI: 1.01-2.5; P = 0.04) and 1-year access reintervention (HR: 1.46, 95% CI: 1.12-1.89), but had similar 1-year access occlusion (HR: 1.2, 95% CI: 0.95-1.51, P = 0.13). CONCLUSIONS: Compared with RA/LA use, GA use in patients undergoing outpatient BCF creations was associated with increased hospital admissions, decreased access utilization at 3 months, and similar 1-year access occlusion and reintervention. RA/LA is preferable to expedite recovery and access utilization.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Levin SR, Farber A, Malas MB, et al. Association of Anesthesia Type with Outcomes after Outpatient Brachiocephalic Arteriovenous Fistula Creation. Ann Vasc Surg. 2020. PMID: 32504791. doi:10.1016/j.avsg.2020.05.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。